Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2010 | 07-2009 | 07-2008 | 07-2007 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 13,125 | 14,494 | 19,057 | 11,379 |
| Receivables | 1,365 | 1,053 | 349 | 902 |
| Inventories | 780 | 858 | 458 | 539 |
| TOTAL | $15,668 | $17,454 | $20,310 | $13,007 |
| Non-Current Assets | ||||
| PPE Net | 1,987 | 1,809 | 1,151 | 1,139 |
| Investments And Advances | 0 | 56 | 95 | 1 |
| Intangibles | N/A | 0 | 110 | 126 |
| Other Non-Current Assets | 459 | 0 | 0 | 0 |
| TOTAL | $2,446 | $1,865 | $1,356 | $1,266 |
| Total Assets | $18,114 | $19,319 | $21,666 | $14,273 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,435 | 1,299 | 598 | 565 |
| Accrued Expenses | 821 | 834 | 546 | 974 |
| TOTAL | $2,281 | $2,158 | $1,144 | $1,539 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 72 | 98 | 0 | 0 |
| TOTAL | $72 | $98 | $0 | $0 |
| Total Liabilities | $2,353 | $2,256 | $1,144 | $1,539 |
| Shareholders' Equity | ||||
| Retained earnings | -85,793 | -72,794 | -58,692 | -51,728 |
| Other shareholders' equity | 5,659 | 3,489 | 3,325 | 5,152 |
| TOTAL | $15,761 | $17,063 | $20,522 | $12,734 |
| Total Liabilities And Equity | $18,114 | $19,319 | $21,666 | $14,273 |